Today's Daily Dose brings you news about Akcea's promising trial results of antisense drug AKCEA-APOCIII-LRx, Applied Genetic's upcoming event, the near-term catalyst of Baudax Bio and Sierra Oncology's reverse stock split.
from RTT - Biotech https://ift.tt/36fB0ep
via IFTTT
No comments:
Post a Comment